Stemcells, Inc. And Advanced Cell Technology: The Race To Treat AMD

In my last two articles; " Advanced Cell Technology: A Balanced Perspective Of Risk and Reward " and " StemCells, Inc., And Neuralstem, Inc.: A Side-By-Side Analysis ", I first took a broad, balanced view of the investment risk and return profile of Advanced Cell Technology based on recent developments, and in my second article, I took an even ... (more)

http://ift.tt/1f7JK43